AG556 acts as an EGFR inhibitor and, although the role of 5-LO in tumor development and progression is not yet fully understood, combined EGFR and 5-LO inhibition was found to be beneficial [21, 42]. The gene discussed is ALOX5; the disease is neoplasm.